AAAAAA

   
Results: 1-10 |
Results: 10
RANDOMIZED TRIAL OF EFFECT OF CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS
Authors: ROUX C ORIENTE P LAAN R HUGHES RA ITTNER J GOEMAERE S DIMUNNO O POUILLES JM HORLAIT S CORTER B
Citation: C. Roux et al., RANDOMIZED TRIAL OF EFFECT OF CYCLICAL ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS, The Journal of clinical endocrinology and metabolism, 83(4), 1998, pp. 1128-1133
IPRIFLAVONE PREVENTS RADIAL BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS OVER 2 YEARS
Authors: ADAMI S BUFALINO L CERVETTI R DIMARCO C DIMUNNO O FANTASIA L ISAIA GC SERNI U VECCHIET L PASSERI M CASTIGLIONE GN GARDINI F LETIZIA G OCCHIPINTI L PARDINI N AGAMENNONE M SCIOLLA A MATUCCI A RIBOLDI R COSTI D DALLAGLIO E PEDRAZZONI M
Citation: S. Adami et al., IPRIFLAVONE PREVENTS RADIAL BONE LOSS IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS OVER 2 YEARS, Osteoporosis international, 7(2), 1997, pp. 119-125
ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS - A RANDOMIZED PLACEBO-CONTROLLED PROSPECTIVE-STUDY
Authors: ROUX C ORIENTE P LAAN R HUGHES RA ITTNER J KAUFMAN JM DIMUNNO O POUILLES JM HORLAIT S CORTET B
Citation: C. Roux et al., ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS - A RANDOMIZED PLACEBO-CONTROLLED PROSPECTIVE-STUDY, Journal of bone and mineral research, 12, 1997, pp. 627-627
EFFECT OF CHRONIC TREATMENT WITH IPRIFLAVONE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS
Authors: GENNARI C ADAMI S AGNUSDEI D BUFALINO L CERVETTI R CREPALDI G DIMARCO C DIMUNNO O FANTASIA L ISAIA GC MAZZUOLI GF ORTOLANI S PASSERI M SERNI U VECCHIET L
Citation: C. Gennari et al., EFFECT OF CHRONIC TREATMENT WITH IPRIFLAVONE IN POSTMENOPAUSAL WOMEN WITH LOW BONE MASS, Calcified tissue international, 61, 1997, pp. 19-22
ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS - A RANDOMIZED PLACEBO-CONTROLLED PROSPECTIVE-STUDY
Authors: ROUX C ORIENTE P LAAN R HUGHES RA ITTNER I KAUFMAN IM DIMUNNO O POUILLES IM HORLAIT S CORTET B
Citation: C. Roux et al., ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED BONE LOSS - A RANDOMIZED PLACEBO-CONTROLLED PROSPECTIVE-STUDY, Arthritis and rheumatism, 40(9), 1997, pp. 627-627
DEFLAZACORT VERSUS METHYLPREDNISOLONE IN POLYMYALGIA-RHEUMATICA - REPLY
Authors: DIMUNNO O MAZZANTINI M
Citation: O. Dimunno et M. Mazzantini, DEFLAZACORT VERSUS METHYLPREDNISOLONE IN POLYMYALGIA-RHEUMATICA - REPLY, Journal of rheumatology, 23(7), 1996, pp. 1307-1307
THE USE OF STABLE TRACERS TO STUDY INTESTINAL CALCIUM-ABSORPTION
Authors: MAZZUOLI GF PASSERI M GENNARI C BONUCCI E DIMUNNO O FIORE CE ISAIA GC NUTI R MINISOLA S HEANEY RP MIONI G
Citation: Gf. Mazzuoli et al., THE USE OF STABLE TRACERS TO STUDY INTESTINAL CALCIUM-ABSORPTION, Bone, 17(3), 1995, pp. 315-317
EFFECTS OF SHORT-TERM, HIGH-DOSE, HEPARIN-THERAPY ON BIOCHEMICAL MARKERS OF BONE METABOLISM
Authors: CANTINI F NICCOLI L BELLANDI F DIMUNNO O
Citation: F. Cantini et al., EFFECTS OF SHORT-TERM, HIGH-DOSE, HEPARIN-THERAPY ON BIOCHEMICAL MARKERS OF BONE METABOLISM, Clinical rheumatology, 14(6), 1995, pp. 663-666
REDUCED BONE MASS AND NORMAL CALCIUM-METABOLISM IN SYSTEMIC-SCLEROSISWITH AND WITHOUT CALCINOSIS
Authors: DIMUNNO O MAZZANTINI M MASSEI P FERDEGHINI M PITARO N LATORRACA A FERRI C
Citation: O. Dimunno et al., REDUCED BONE MASS AND NORMAL CALCIUM-METABOLISM IN SYSTEMIC-SCLEROSISWITH AND WITHOUT CALCINOSIS, Clinical rheumatology, 14(4), 1995, pp. 407-412
DEFLAZACORT VERSUS METHYLPREDNISOLONE IN POLYMYALGIA-RHEUMATICA - CLINICAL EQUIVALENCE AND RELATIVE ANTIINFLAMMATORY POTENCY OF DIFFERENT TREATMENT REGIMENS
Authors: DIMUNNO O IMBIMBO B MAZZANTINI M MILANI S OCCHIPINTI G PASERO G
Citation: O. Dimunno et al., DEFLAZACORT VERSUS METHYLPREDNISOLONE IN POLYMYALGIA-RHEUMATICA - CLINICAL EQUIVALENCE AND RELATIVE ANTIINFLAMMATORY POTENCY OF DIFFERENT TREATMENT REGIMENS, Journal of rheumatology, 22(8), 1995, pp. 1492-1498
Risultati: 1-10 |